An investigational therapy is demonstrating preclinical promise against non-Hodgkin lymphoma by boosting natural killer cells ...

The biotech company, which has dual headquarters in Seattle and Houston, adds to a $60 million Series A round it closed last ...

He further explained he was diagnosed with a slow-growing "bone marrow cancer" called Waldenström's macroglobulinemia (WM): ...

Irvine, California Monday, December 23, 2024, 18:00 Hrs [IST] ...

The global market for intraocular lymphoma therapy is expected to be worth USD 1.2 billion by the year of 2023. The market, ...

The inMIND trial results have elevated expectations for Monjuvi's commercial success, but competition is on the horizon.

Rachel Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with ...

Global Refractory Follicular Lymphoma Diagnostics Market Projected to Reach USD 464.47 Million by 2029 Refractory Follicular ...

Santiago has been in remission since 2022 after ringing a large golden bell reserved for little heroes in Miami-Dade County.